Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
30.43
-2.71 (-8.18%)
At close: Feb 21, 2025, 4:00 PM
31.00
+0.57 (1.87%)
After-hours: Feb 21, 2025, 6:57 PM EST
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.42 billion as of February 21, 2025. Its market cap has increased by 9.51% in one year.
Market Cap
2.42B
Enterprise Value
1.66B
1-Year Change
9.51%
Ranking
Category
Stock Price
$30.43
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.42B, an increase of 638.47%. That is a compound annual growth rate of 48.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 2.42B | 22.70% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |